Home Evaluation of the antianxiety and antidepressant activities of mosapride in Wistar albino rats
Article
Licensed
Unlicensed Requires Authentication

Evaluation of the antianxiety and antidepressant activities of mosapride in Wistar albino rats

  • Vybhava Krishna , KL Bairy , Navin Patil EMAIL logo and Sweenly V. Sunny
Published/Copyright: July 18, 2019

Abstract

Background

The 5HT4 receptor agonists are antidepressants with a unique mode of action. Many studies have been done on investigational drugs, and mosapride has been shown to have a 5HT3 antagonistic property. In this study, we assessed the potential anxiolytic and antidepressant effects of mosapride on Wistar albino rats.

Methods

The rats were randomly assigned to two models containing 4 groups of 6 animals each. In the anxiety model, four groups included 0.5 mL of 0.5% carboxymethyl cellulose (CMC), mosapride 1.5 mg/kg, mosapride 3 mg/kg and diazepam 2 mg/kg. They were dosed for 5 days. On the 3rd day, the elevated plus maze (EPM) was conducted, and on the 5th day, the open field (OF) tests were conducted. In the depression model, four groups included 0.5 mL of 0.5% CMC, mosapride 1.5 mg/kg, mosapride 3 mg/kg and imipramine 30 mg/kg. After 3 days of dosing, the forced swim test (FST) was conducted, followed by a washout period of 1 month. Then, the rats were subjected to chronic unpredictable stress with sucrose preference.

Results

Compared with the control, the mosapride-treated animals showed significant anxiolytic behavior at both high and low doses in the EPM and OF tests. In the FST, both high and low doses of mosapride reduced immobility. The climbing behavior was prominent at a high dose of mosapride, whereas swimming was prominent at a low dose. In the chronic stress model, both doses of mosapride preserved sucrose preference comparable to imipramine.

Conclusion

These findings suggest that mosapride has anxiolytic and antidepressant activities at clinically used doses.

  1. Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.

  2. Research funding: None declared.

  3. Employment or leadership: None declared.

  4. Honorarium: None declared.

  5. Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.

References

[1] World Health Organization. Depression and other common mental disorders: global health estimates. World Heal Organ [Internet]. 2017;1–24. Available at: http://apps.who.int/iris/bitstream/10665/254610/1/WHO-MSD-MER-2017.2-eng.pdf. Accessed: 4 July 2017.Search in Google Scholar

[2] Koloski NA, Jones M, Talley NJ. Evidence that independent gut-to-brain and brain-to-gut pathways operate in the irritable bowel syndrome and functional dyspepsia: a 1-year population-based prospective study. Aliment Pharmacol Ther 2016;44:592–600.10.1111/apt.13738Search in Google Scholar

[3] Lucas G, Debonnel G. 5-HT4 receptors exert a frequency-related facilitatory control on dorsal raphé nucleus 5-HT neuronal activity. Eur J Neurosci 2002;16:817–22.10.1046/j.1460-9568.2002.02150.xSearch in Google Scholar

[4] Mendez-David I, David DJ, Darcet F, Wu MV, Kerdine-Römer S, Gardier AM, et al. Rapid Anxiolytic Effects of a 5-HT4 Receptor Agonist Are Mediated by a Neurogenesis-Independent Mechanism. Neuropsychopharmacology 2014;39:1366–78.10.1038/npp.2013.332Search in Google Scholar

[5] Kii Y, Ito T. Drug-induced ventricular tachyarrhythmia in isolated rabbit hearts with atrioventricular block. Pharmacol Toxicol 2002;90:246–53.10.1034/j.1600-0773.2002.900504.xSearch in Google Scholar

[6] Paget GE, Barnes JM. Toxicity tests. In: Lawrence DR B AL, editor. Evaluation of drug activities pharmacometrics. London, New York: Academic Press, 1964:135–65.10.1016/B978-1-4832-2845-7.50012-8Search in Google Scholar

[7] Kurt M, Arik AC, Çelik S. The effects of sertraline and fluoxetine on anxiety in the elevated plus-maze test. J Basic Clin Physiol Pharmacol 2000;11:173–80.10.1515/JBCPP.2000.11.2.173Search in Google Scholar

[8] Kroczka B, Branski P, Palucha A, Pilc A, Nowak G. Antidepressant-like properties of zinc in rodent forced swim test. Brain Res Bull 2001;55:297–300.10.1016/S0361-9230(01)00473-7Search in Google Scholar

[9] Walf AA, Frye CA. The use of the elevated plus maze as an assay of anxiety-related behavior in rodents. Nat Protoc 2007;2:322–8.10.1038/nprot.2007.44Search in Google Scholar

[10] Jähkel M, Rilke O, Koch R, Oehler J. Open field locomotion and neurotransmission in mice evaluated by principal component factor analysis-effects of housing condition, individual activity disposition and psychotropic drugs. Prog Neuropsychopharmacol Biol Psychiatry 2000;24:61–84.10.1016/S0278-5846(99)00081-0Search in Google Scholar

[11] Lucki I, Dalvi A, Mayorga AJ. Sensitivity to the effects of pharmacologically selective antidepressants in different strains of mice. Psychopharmacology (Berl) 2001;155:315–22.10.1007/s002130100694Search in Google Scholar PubMed

[12] Parihar VK, Hattiangady B, Kuruba R, Shuai B, Shetty AK. Predictable chronic mild stress improves mood, hippocampal neurogenesis and memory. Mol Psychiatry 2011;16:171–83.10.1038/mp.2009.130Search in Google Scholar

[13] Strekalova T, Spanagel R, Bartsch D, Henn FA, Gass P. Stress-Induced anhedonia in mice is associated with deficits in forced swimming and exploration. Neuropsychopharmacology 2004;29:2007–17.10.1038/sj.npp.1300532Search in Google Scholar

[14] Bockaert J, Claeysen S, Compan V, Dumuis A. 5-HT4 receptors. Curr Drug Targets CNS Neurol Disord 2004;3:39–51.10.2174/1568007043482615Search in Google Scholar

[15] Lucas G, Rymar VV, Du J, Mnie-Filali O, Bisgaard C, Manta S, et al. Serotonin4 (5-HT4) receptor agonists are putative antidepressants with a rapid onset of action. Neuron 2007;55:712–25.10.1016/j.neuron.2007.07.041Search in Google Scholar

[16] Pascual-Brazo J, Castro E, Díaz Á, Valdizán EM, Pilar-Cuéllar F, Vidal R, et al. Modulation of neuroplasticity pathways and antidepressant-like behavioural responses following the short-term (3 and 7 days) administration of the 5-HT4 receptor agonist RS67333. Int J Neuropsychopharmacol 2012 2;15:631–43.10.1017/S1461145711000782Search in Google Scholar

[17] Willner P. Chronic mild stress (CMS) revisited: consistency and behavioural-neurobiological concordance in the effects of CMS. Neuropsychobiology 2005;52:90–110.10.1159/000087097Search in Google Scholar

[18] Kumar B, Kuhad A, Chopra K. Neuropsychopharmacological effect of sesamol in unpredictable chronic mild stress model of depression: behavioral and biochemical evidences. Psychopharmacology (Berl) 2011;214:819–28.10.1007/s00213-010-2094-2Search in Google Scholar

[19] Strekalova T, Gorenkova N, Schunk E, Dolgov O, Bartsch D. Selective effects of citalopram in a mouse model of stress-induced anhedonia with a control for chronic stress. Behav Pharmacol [Internet]. 2006;17:271–87.10.1097/00008877-200605000-00008Search in Google Scholar

[20] Mongeau R, Blier P, De Montigny C. The serotonergic and noradrenergic systems of the hippocampus: Their interactions and the effects of antidepressant treatments. Brain Research Reviews 1997;23:145–95.10.1016/S0165-0173(96)00017-3Search in Google Scholar

[21] Kurhe Y, Mahesh R, Gupta D, Thangaraj D. Effect of (4a) a novel 5-HT3 receptor antagonist on chronic unpredictable mild stress induced depressive-like behavior in mice: an approach using behavioral tests battery. J Basic Clin Physiol Pharmacol 2015;26:25–33.10.1515/jbcpp-2013-0160Search in Google Scholar PubMed

Received: 2018-05-24
Accepted: 2018-11-15
Published Online: 2019-07-18

© 2019 Walter de Gruyter GmbH, Berlin/Boston

Articles in the same Issue

  1. Minireview
  2. Glial pathology in neuropsychiatric disorders: a brief review
  3. Original Articles
  4. Fenugreek seed extract ameliorates cognitive deficits in streptozotocin-induced diabetic rats
  5. The effect of silymarin supplementation on cognitive impairment induced by diabetes in rats
  6. Evaluation of the antianxiety and antidepressant activities of mosapride in Wistar albino rats
  7. Sexual stimulant effects of the mixture of Mondia whitei, Dracaena arborea, and Bridelia ferruginea in normal and prediabetic male Wistar rats
  8. Evaluating exercise challenge to validate cardiac autonomic dysfunction in lean PCOS phenotype
  9. Involvement of proinflammatory cytokines and metallothionein in the repairing of arsenic-mediated uterine tissue damage by curcumin
  10. Antioxidant potentials and effects on the hematology and osmotic fragility scores of a polyherbal formulation used in Southeast Nigeria
  11. Protective mechanisms of protocatechuic acid against doxorubicin-induced nephrotoxicity in rat model
  12. Phytochemicals and antidiabetic activity of the aqueous extract of the Punica granatum fruit in streptozotocin-induced diabetic mice
  13. Ficus cunia Buch.-Ham. ex Roxb. (leaves): An experimental evaluation of the cytotoxicity, thrombolytic, analgesic and neuropharmacological activities of its methanol extract
  14. Ameliorative effects of Annona muricata Linn. (Annonaceae) against potassium dichromate-induced hypertension in vivo: involvement of Kim-1/p38 MAPK/Nrf2 signaling
  15. Case Report
  16. A rare case of clomiphene-induced leukocytoclastic vasculitis
Downloaded on 11.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/jbcpp-2018-0089/html
Scroll to top button